NASDAQ:MDXG • US6024961012
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MIMEDX GROUP INC (MDXG).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-23 | Citizens | Initiate | Market Outperform |
| 2026-02-17 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-20 | Lake Street | Maintains | Buy -> Buy |
| 2025-12-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-31 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-07-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-01 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-07-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | Lake Street | Initiate | Buy |
| 2024-03-01 | Mizuho | Maintains | Buy -> Buy |
| 2023-10-31 | Mizuho | Maintains | Buy -> Buy |
| 2023-10-27 | Craig-Hallum | Initiate | Buy |
| 2023-08-02 | Mizuho | Maintains | Buy -> Buy |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-03 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-13 | Mizuho | Initiate | Buy |
| 2022-09-07 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-14 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-26 | Northland Capital Markets | Initiate | Outperform |
| 2021-03-19 | HC Wainwright & Co. | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 321.477M 20.04% | 348.879M 8.52% | 418.63M 19.99% | 354.36M -15.35% | 400.94M 13.14% | 442.22M 10.30% | 470.63M 6.42% | 528.16M 12.22% | |
| EBITDA YoY % growth | 45.719M 622.50% | 56.654M 23.92% | 78.768M 39.03% | 57.477M -27.03% | 77.724M 35.23% | 103.89M 33.67% | 106.18M 2.20% | 124.64M 17.39% | |
| EBIT YoY % growth | 42.292M 430.41% | 50.613M 19.68% | 63.887M 26.23% | 22.734M -64.42% | 48.284M 112.39% | 116.38M 141.03% | 72.012M -38.12% | 89.25M 23.94% | |
| Operating Margin | 13.16% | 14.51% | 15.26% | 6.42% | 12.04% | 26.32% | 15.30% | 16.90% | |
| EPS YoY % growth | 0.32 196.97% | 0.29 -9.37% | 0.41 41.38% | 0.12 -71.81% | 0.24 105.89% | 0.33 37.14% | 0.37 12.50% | 0.45 22.22% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -131.16% | 0.01 -86.40% | 0.10 -32.00% | 0.11 12.20% | 0.06 427.33% | 0.10 650.19% | 0.13 30.00% | 0.16 45.45% |
| Revenue Q2Q % growth | 70.856M -19.67% | 82.016M -16.82% | 113.15M -0.51% | 119.85M 1.49% | 94.35M 33.16% | 107.2M 30.71% | 116.99M 3.39% | 128.42M 7.15% |
| EBITDA Q2Q % growth | 6.885M -39.89% | 12.674M -32.37% | 28.662M -15.33% | 29.988M -16.60% | 12.546M 82.22% | 22.338M 76.25% | 26.928M -6.05% | 34.068M 13.61% |
| EBIT Q2Q % growth | -2.882M -134.92% | 2.591M -79.05% | 16.422M -25.99% | 20.349M -3.45% | 7.956M 376.11% | 17.748M 584.99% | 22.338M 36.02% | 29.478M 44.86% |
All data in USD
12 analysts have analysed MDXG and the average price target is 9.86 USD. This implies a price increase of 105.2% is expected in the next year compared to the current price of 4.805.
MIMEDX GROUP INC (MDXG) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of MIMEDX GROUP INC (MDXG) is -0.02 USD and the consensus revenue estimate is 70.86M USD.
The expected long term growth rate for MIMEDX GROUP INC (MDXG) is 2.1%.